Physician profile
Haley Dalton
NPI 1922350586
$752.11
in general payments reported to CMS, 2019-2025
18 companies · $207 in 2025
The $207 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $143 · 2023: $116 · 2024: $286 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $509 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $509.45 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $183.71 | 2021-2025 | Veozah |
| Shield Therapeutics INC | $160.76 | 2024-2025 | |
| Aspira Women'S Health INC | $47.31 | 2021 | |
| Axonics, INC. | $46.28 | 2023 | Axonics |
| Pfizer INC. | $42.72 | 2024-2025 | |
| Northgate Technologies, INC. | $34.87 | 2024 | Stimsite |
| Ironshore Pharmaceuticals INC. | $32.42 | 2023 | Jornay Pm |
| Corium, LLC | $27.00 | 2024 | Azstarys |
| Hologic Sales and Service, LLC | $24.86 | 2021-2025 | Novasure |
| Bayer Healthcare Pharmaceuticals INC. | $20.80 | 2025 | |
| Sanofi Pasteur INC. | $20.36 | 2023 | |
| Sumitomo Pharma America, INC. | $19.57 | 2025 | Gemtesa |
| Abbvie INC. | $17.21 | 2021 | |
| Becton, Dickinson and Company | $16.72 | 2021 | |
| Verrica Pharmaceuticals INC. | $16.68 | 2023 | Ycanth |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $14.69 | 2025 | Femlyv |
| Collegium Pharmaceutical, INC. | $13.54 | 2025 | Jornay Pm |
| Amgen INC. | $12.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Dalton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.